Qube Research & Technologies (QRT)’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-132,600	Closed	-$11.9M	–	3934
2024 Q4	$11.9M	Hold	132,600	–	–	0.02%	989
2024 Q3	$13.1M	Buy	132,600 +8,900	+7%	+$874K	0.02%	878
2024 Q2	$11.5M	Sell	123,700 -7,800	-6%	-$699K	0.02%	851
2024 Q1	$12.5M	Buy	131,500 +130,900	+21,817%	+$12.1M	0.02%	753
2023 Q4	$53.6K	Sell	600 -19,600	-97%	-$1.46M	﹤0.01%	3295
2023 Q3	$1.48M	Buy	+20,200	New	+$1.61M	﹤0.01%	1546

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Qube Research & Technologies (QRT)'s XBI Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its State Street SPDR S&P Biotech ETF (XBI) stake by 146% in Q1 2026, buying an estimated $14.1M and bringing the position to 190,717 shares worth $24.4M. The position accounts for 0.03% of the portfolio, ranked #770.

Qube Research & Technologies (QRT) first reported a position in XBI in Q1 2020 and has held it in 17 quarters since. The position peaked at $28.6M in Q4 2020. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Qube Research & Technologies (QRT) held 190,717 shares of State Street SPDR S&P Biotech ETF worth $24.4M as of Q1 2026.
Qube Research & Technologies (QRT) bought 113,217 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $14.1M.
State Street SPDR S&P Biotech ETF made up 0.03% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #770 holding.
Qube Research & Technologies (QRT) first reported a position in State Street SPDR S&P Biotech ETF in Q1 2020 and has held it in 17 quarters since.
Qube Research & Technologies (QRT)'s State Street SPDR S&P Biotech ETF position peaked at $28.6M in Q4 2020.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.